<div id="Stage" class="EDGE-196569901"></div>

The RA Series Provides...

updates on diagnosis, management, and treatment options for the RA community. This companion site incorporates content from live meetings and is a resource for web links, CME activities, reference literature, and resources for both patients and providers. At Med Learning Group, we hope that this educational series will offer timely and practical management and treatment information to both inform clinicians and help improve patient care and quality of life for those people living with RA.

About Healthy Days

The Healthy Days initiative provides valuable information about the symptoms, treatment, and disease course of rheumatoid arthritis (RA) through live and online CME offerings for healthcare providers. Our goal is to increase awareness of evidence-based approaches to managing RA through personalized medicine. By reviewing the most recent clinical trial data for existing and investigational therapies for RA, we hope to improve patient care and communication among patients, caregivers, and healthcare providers.

The Provider Toolkit

The information in this “Provider Toolkit” is designed to supplement your current knowledge on RA, and includes several resources such as additional reading, links to RA and neurological societies, challenges and epidemiology associated with RA, and basic information on symptoms, diagnosis and treatment.

The Patient Toolkit

Knowing as much as possible about the disease will help you and your care team make the best decisions for you, the patient. The information contained in this “Patient Toolkit” is designed to answer several of your questions and provide education on certain aspects of the disease. We include several types of information such as frequently asked questions, resources for additional reading and national societies, and tips on living with RA.

Welcome to Healthy Days

Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease of unknown etiology that is characterized by joint swelling and tenderness, along with destruction of synovial joints. The health-related quality of life in patients with RA is significantly reduced by the pain, fatigue, and loss of mobility, resulting in significant economic impact associated with disease progression (Bansback 2009).

The past decade has seen tremendous advances in rheumatoid arthritis diagnosis and treatment. Patients at high risk of RA can now be identified and treated earlier in the course of the disease. A variety of outcomes measures, especially in terms of health related quality of life, can be incorporated into treatment targets, along with simplified disease activity scores. New treatments, along with innovative dosing and combination strategies, offer patients a good chance of remission, or at least of reduced disease activity.

The Healthy Days initiative provides updates on the management and treatment of RA. This companion site incorporates content from recent literature and is a resource for web links, CME activities, reference literature, and resources for both patients and providers. At Med Learning Group, we hope that this educational series will offer timely and practical management and treatment information to both inform clinicians and help improve patient care and quality of life for those people living with RA.

Americans Living with RA today

(Estimated) Americans Living with RA by 2050

(Estimated) Americans Dying with RA in 2016

2016 Costs of RA in the US

CME Activities

Provider Toolkit

Patient Toolkit